ADC Therapeutics
VerifiedDevelops proprietary antibody drugs targeting cancer. Learn more
Launch date
Employees
Market cap
-
Net debt
-
Enterprise valuation
$252m (Public information from May 2024)
Share price
$4.57 ADCT
Company register number CH-550.1.094.173-1
Epalinges Canton of Vaud (HQ)